SE465352B - Anvaendning av diltiazem foer framstaellning av ett laekemedel foer behandling av hyperlipidemi - Google Patents
Anvaendning av diltiazem foer framstaellning av ett laekemedel foer behandling av hyperlipidemiInfo
- Publication number
- SE465352B SE465352B SE8403042A SE8403042A SE465352B SE 465352 B SE465352 B SE 465352B SE 8403042 A SE8403042 A SE 8403042A SE 8403042 A SE8403042 A SE 8403042A SE 465352 B SE465352 B SE 465352B
- Authority
- SE
- Sweden
- Prior art keywords
- diltiazem
- hyperlipidemia
- treatment
- medicine
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58104691A JPS59231018A (ja) | 1983-06-10 | 1983-06-10 | 抗脂血剤 |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8403042D0 SE8403042D0 (sv) | 1984-06-06 |
SE8403042L SE8403042L (sv) | 1984-12-11 |
SE465352B true SE465352B (sv) | 1991-09-02 |
Family
ID=14387491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8403042A SE465352B (sv) | 1983-06-10 | 1984-06-06 | Anvaendning av diltiazem foer framstaellning av ett laekemedel foer behandling av hyperlipidemi |
Country Status (12)
Country | Link |
---|---|
JP (1) | JPS59231018A (fr) |
BE (1) | BE899867A (fr) |
CH (1) | CH661867A5 (fr) |
DE (1) | DE3419425A1 (fr) |
DK (1) | DK164021C (fr) |
FR (1) | FR2547730B1 (fr) |
GB (1) | GB2141027B (fr) |
HK (1) | HK45489A (fr) |
IT (1) | IT1196710B (fr) |
NL (1) | NL8401793A (fr) |
SE (1) | SE465352B (fr) |
SG (1) | SG21089G (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4778791A (en) * | 1986-05-16 | 1988-10-18 | Tanabe Seiyaku Co., Ltd. | Pharmaceutical composition for improving constitution of lipids in blood |
JPS63107925A (ja) * | 1986-05-23 | 1988-05-12 | Tanabe Seiyaku Co Ltd | 動脈硬化症予防・治療剤 |
AT389446B (de) * | 1987-10-08 | 1989-12-11 | Tanabe Seiyaku Co | Verwendung eines 8-chlorobenzothiazepins zur herstellung eines arzneimittels |
DE3737741A1 (de) * | 1987-11-06 | 1989-05-18 | Goedecke Ag | Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid |
GB9423172D0 (en) * | 1994-11-17 | 1995-01-04 | Wellcom Foundation The Limited | Hypolipidemic benzothiazepines |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3562257A (en) * | 1967-10-28 | 1971-02-09 | Tanabe Seiyaku Co | Benzothiazepine derivatives |
JPS58208222A (ja) * | 1982-05-28 | 1983-12-03 | Japan Found Cancer | 抗腫瘍剤効果増強剤 |
JPS5970611A (ja) * | 1982-10-15 | 1984-04-21 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
-
1983
- 1983-06-10 JP JP58104691A patent/JPS59231018A/ja active Granted
-
1984
- 1984-05-24 DE DE19843419425 patent/DE3419425A1/de active Granted
- 1984-06-05 NL NL8401793A patent/NL8401793A/nl not_active Application Discontinuation
- 1984-06-06 SE SE8403042A patent/SE465352B/sv not_active IP Right Cessation
- 1984-06-07 GB GB08414498A patent/GB2141027B/en not_active Expired
- 1984-06-08 IT IT67596/84A patent/IT1196710B/it active
- 1984-06-08 BE BE0/213101A patent/BE899867A/fr not_active IP Right Cessation
- 1984-06-08 DK DK284084A patent/DK164021C/da not_active IP Right Cessation
- 1984-06-08 FR FR8409077A patent/FR2547730B1/fr not_active Expired
- 1984-06-12 CH CH2838/84A patent/CH661867A5/de not_active IP Right Cessation
-
1989
- 1989-04-07 SG SG210/89A patent/SG21089G/en unknown
- 1989-06-07 HK HK454/89A patent/HK45489A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPS6317810B2 (fr) | 1988-04-15 |
NL8401793A (nl) | 1985-01-02 |
BE899867A (fr) | 1984-10-01 |
CH661867A5 (de) | 1987-08-31 |
IT8467596A1 (it) | 1985-12-08 |
IT1196710B (it) | 1988-11-25 |
DK284084A (da) | 1984-12-11 |
DK284084D0 (da) | 1984-06-08 |
FR2547730A1 (fr) | 1984-12-28 |
HK45489A (en) | 1989-06-16 |
GB8414498D0 (en) | 1984-07-11 |
SE8403042L (sv) | 1984-12-11 |
JPS59231018A (ja) | 1984-12-25 |
SG21089G (en) | 1990-01-26 |
DE3419425A1 (de) | 1984-12-13 |
DE3419425C2 (fr) | 1989-06-08 |
GB2141027B (en) | 1986-10-22 |
IT8467596A0 (it) | 1984-06-08 |
FR2547730B1 (fr) | 1987-11-13 |
DK164021B (da) | 1992-05-04 |
SE8403042D0 (sv) | 1984-06-06 |
GB2141027A (en) | 1984-12-12 |
DK164021C (da) | 1992-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3879080T2 (de) | Pharmazeutische matrix mit verzoegerter freisetzung und verfahren. | |
KR0164435B1 (ko) | 비만증 치료용 약제학적 조성물 | |
US4268524A (en) | Method of treating abnormal lipoprotein ratios with acylcarnitine | |
SK2612002A3 (en) | Pharmaceutical formulation containing benzamide derivative with improved solubility and oral absorptivity | |
US6566400B1 (en) | Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants | |
SE465352B (sv) | Anvaendning av diltiazem foer framstaellning av ett laekemedel foer behandling av hyperlipidemi | |
US3144387A (en) | Anti-inflammatory compositions | |
AU666992B2 (en) | Pharmaceutical composition for preventing or treating arteriosclerosis | |
KR860006265A (ko) | 9,10-디하이드로 에르고트 알카로이드를 함유하는 서방성 제재의 제조방법 | |
JPS62106016A (ja) | 免疫抑制剤 | |
FI89004B (fi) | Anvaendning av tillsatsmedel foer oekning av absorptionshastigheten av laekemedel i orala laekemedelspreparat | |
EP0600582A1 (fr) | Traitement de dystrophie musculaire | |
Upadhyay et al. | Studies on Formulation and optimization of Gastro Retentive multi-Particulates of Glibenclamide and Metformin hydrochloride for the treatment of Type II Diabetes mellitus using Gelucire: A Review | |
JPS5938207B2 (ja) | 腎疾患治療剤 | |
US4311694A (en) | Amorphous coprecipitates of 4-(monoalkylamino) benzoic acid and derivatives and certain water-soluble materials | |
JPS6137731A (ja) | グアバ葉エキスを有効成分とする経口糖尿病薬 | |
RU2141314C1 (ru) | Противовирусный препарат "амиксин" и способ его получения | |
US20070082903A1 (en) | Remedy for rheumatoid arthritis | |
RU2002115814A (ru) | Лечение системной красной волчанки с помощью дегидроэпиандростерона | |
JPS58140017A (ja) | 心不全治療剤 | |
JP3186365B2 (ja) | 肝疾患治療薬 | |
JPH03287531A (ja) | 膵炎治療薬 | |
EP1941910A1 (fr) | Forme pharmaceutique destinee au traitement de cas aigus et d'exacerbations chez des patients souffrant de polyarthrite rhumatoide et de troubles aigus associes | |
JPH03232870A (ja) | チオアミド化合物 | |
JPS6360926A (ja) | 感冒薬 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8403042-8 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 8403042-8 Format of ref document f/p: F |